載入...
Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial
BACKGROUND: Biological considerations suggest that renin–angiotensin system inhibitors might influence the severity of COVID-19. We aimed to evaluate whether continuing versus discontinuing renin–angiotensin system inhibitors (angiotensin-converting enzyme inhibitors or angiotensin receptor blockers...
Na minha lista:
| 發表在: | Lancet Respir Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier Ltd.
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7832152/ https://ncbi.nlm.nih.gov/pubmed/33422263 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2213-2600(20)30558-0 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|